Literature DB >> 2826533

Soluble Plasmodium falciparum antigens contain carbohydrate moieties important for immune reactivity.

P H Jakobsen1, T G Theander, J B Jensen, K Mølbak, S Jepsen.   

Abstract

The importance of carbohydrate moieties for the antigenicity of purified soluble Plasmodium falciparum antigens from the asexual blood stage was tested. Digestion of the soluble antigens with alpha-D-galactosidase clearly affected the ability of the antigen to react with malaria-immune sera from different geographical origins in crossed immunoelectrophoresis and immunoblotting. Antigens of 220, 180, 80, and 74 kilodaltons were affected by the enzyme treatment. Furthermore, the enzyme digestion reduced the ability of the purified soluble antigen to stimulate lymphocytes from malaria-immune donors. The results might have important implications for the strategy of developing a malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826533      PMCID: PMC269414          DOI: 10.1128/jcm.25.11.2075-2079.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins.

Authors:  R Ramasamy; R T Reese
Journal:  Mol Biochem Parasitol       Date:  1986-05       Impact factor: 1.759

2.  Synthesis of merozoite proteins and glycoproteins during the schizogony of Plasmodium falciparum.

Authors:  R F Howard; R T Reese
Journal:  Mol Biochem Parasitol       Date:  1984-03       Impact factor: 1.759

3.  Antigens and antibodies in Plasmodium falciparum malaria studied by immunoelectrophoretic methods.

Authors:  S Jepsen; N H Axelsen
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-10

4.  Spontaneously released Plasmodium falciparum merozoites from culture possess glycoproteins.

Authors:  H G Heidrich; W Strych; P Prehm
Journal:  Z Parasitenkd       Date:  1984

5.  Induction of protective immunity to Plasmodium falciparum in Saimiri sciureus monkeys with partially purified exoantigens.

Authors:  M A James; I Kakoma; M Ristic; M Cagnard
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition.

Authors:  J B Jensen; S L Hoffman; M T Boland; M A Akood; L W Laughlin; L Kurniawan; H A Marwoto
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Specific proliferative response of human lymphocytes to purified soluble antigens from Plasmodium falciparum in vitro cultures and to antigens from malaria patients' sera.

Authors:  I C Bygbjerg; S Jepsen; T G Theander; N Odum
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

9.  Immunoadsorbent isolation of antigens from the culture medium of in vitro cultivated Plasmodium falciparum.

Authors:  S Jepsen; B J Andersen
Journal:  Acta Pathol Microbiol Scand C       Date:  1981-04

10.  Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals.

Authors:  T G Theander; I C Bygbjerg; S Jepsen; M Svenson; A Kharazmi; P B Larsen; K Bendtzen
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more
  10 in total

1.  Development of natural immunity in Plasmodium falciparum malaria: study of antibody response by Western immunoblotting.

Authors:  J Thelu; I Sheick-Zakiuddin; C Boudin; F Peyron; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 2.  Glycobiology of Plasmodium falciparum: an emerging area of research.

Authors:  D C Hoessli; E A Davidson; R T Schwarz
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

3.  Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum.

Authors:  P H Jakobsen; L Hviid; T G Theander; E A Afare; R G Ridley; P M Heegaard; D Stuber; K Dalsgaard; F K Nkrumah
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

4.  Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Authors:  J Taverne; C A Bate; D Kwiatkowski; P H Jakobsen; J H Playfair
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Biochemical characterization, localization and immunostimulating properties of a soluble glycoprotein, Ag1, isolated from in vitro cultures of Plasmodium falciparum.

Authors:  P H Jakobsen; S Jepsen; E M Riley; T G Theander; P Grellier; A Lihme; L Hviid; M Dziegiel; J Schrevel
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin.

Authors:  H N Caro; N A Sheikh; J Taverne; J H Playfair; T W Rademacher
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.

Authors:  M Theisen; J Vuust; A Gottschau; S Jepsen; B Høgh
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

9.  Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection.

Authors:  M L Ancelin; M Parant; M J Thuet; J R Philippot; H J Vial
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Immunoglobulin A nephropathy associated with Plasmodium falciparum malaria.

Authors:  Dong Eun Yoo; Jeong Ho Kim; Jeong Hae Kie; Yoonseon Park; Tae Ik Chang; Hyung Jung Oh; Seung Jun Kim; Tae-Hyun Yoo; Kyu Hun Choi; Shin-Wook Kang; Seung Hyeok Han
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.